Skip to main content
NewslettersWatchlist

Gsk Plc ADR(GSK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low39.72
Day High40.23
Open:40.02
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Down 75%. Is Agenus Stock a Buy on the Dip?
Motley Fool
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Motley Fool
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Newswire.ca
Find Therapeutics Announces Appointment of Dr. Anthony Johnson to its Board of Directors
Barchart
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe
Barchart
1 Pharma Stock to Buy Near 52-Week Highs
The Globe and Mail
Market movers: Stocks seeing action on Wednesday - and why
Barchart
2 Best Growth Stocks to Buy with $1,000 Right Now
Barchart
1 Pharma Stock to Buy on Strong Vaccine Growth Potential
Motley Fool
3 Great Foreign Companies to Invest in Right Now
MarketBeat
GSK is a remedy for the winter investment blahs
Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Motley Fool
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Motley Fool
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors?
Barchart
An Under the Radar Healthcare Stock to Add to Your Portfolio
Motley Fool
Is GSK Stock Worth Buying Right Now?
Motley Fool
Why Shares of Vir Biotechnology Are Plunging Thursday
Motley Fool
3 Healthcare Stocks With Healthy Dividends
Motley Fool
3 No-Brainer Stocks to Buy With $50 Right Now
Motley Fool
Better Artificial Intelligence Stock: GSK or Eli Lilly?
Newswire.ca
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health
MarketBeat
Drugmaker GSK: Becoming a Healthier Value Stock
Motley Fool
Is GSK a Strong Buy Right Now?
Motley Fool
Why Shares of CureVac Jumped This Week
Motley Fool
2 Stocks Defying Friday's Market Downturn
Motley Fool
2 Top Healthcare Stocks to Buy Right Now
PR Newswire
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
BayStreet.ca
Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies
Motley Fool
Could Latecomer Moderna Match Big Pharma Rivals in RSV?
Motley Fool
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer
MarketBeat
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results
ACN Newswire
International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

Profile

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.